Development of Amphotericin B Loaded PLGA Nanoparticles for Effective Treatment of Visceral Leishmaniasis

IFMBE Proceedings

Volumn 23, Issue , 2009, Pages 1241-1243

  Nahar, M ^a   Mishra, D ^a   Dubey, V ^a   Jain, N K ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

amphotericin B; nanoparticles; PLGA; visceral leishmaniasis

Indexed keywords

AMPHOTERICIN B; CONTROLLED RELEASE; EMULSION-SOLVENT EVAPORATION METHOD; ENTRAPMENT EFFICIENCY; LIPOSOMAL FORMULATION; PLGA; POLYDISPERSITY INDICES; VISCERAL LEISHMANIASIS;

BIOMEDICAL ENGINEERING; CELL CULTURE; COMMERCE; COPOLYMERS; EMULSIFICATION; MACROPHAGES; TRANSMISSION ELECTRON MICROSCOPY;

NANOPARTICLES;

EID: 84885594881     PISSN: 16800737     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1007/978-3-540-92841-6_304     Document Type: Conference Paper

References (7)

1. Yamey G (2002) The world's most neglected diseases. Br Med J 325: 176-177.
2. Nahar M, Dutta T, Murugesan S, Asthana A, et al. (2006) Functional polymeric nanoparticles: an efficient and promising tool for active delivery of bioactives. Crit Rev Ther Drug Carrier Syst 23,: 259-318.
3. Mittal G, Sahana DK, Bhardwaj V, Ravi Kumar M. N. V (2007) Estradiol loaded PLGA nanoparticles for oral administration: Effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo. J Contr Rel 119: 77-85.
4. Senthilkumar M, Subramanian G, Ranjitkumar A, Nahar M, Mishra P, Jain NK (2007) PEGylated Poly (Lactide-co-Glycolide) (PLGA) nanoparticulate delivery of Docetaxel: synthesis of diblock copolymers, optimization of preparation variables on formulation characteristics and in vitro release studies. J Biomed Nanotech1:52-60.
5. Venier-Julienne M, Benoit J (1996) Preparation, purification and morphology of polymeric nanoparticles as drug carriers. Pharm. Acta Helv 71, 121-128.
6. Dube A, Singh N, Sundar S, Singh N (2005), Refractoriness to the treatment of sodium stibogluconate in Indian kala-azar field isolates persists in in vitro and in vivo experimental models. Parasitol Res 96, 216-23. 7.
7. Guru PY, Agarwal AK, Singhal, UK, Singhal A, Gupta CM (1989) Drug targeting in Leishmania donovani infections using tuftsin bearing liposomes as drug vehicles. FEBS Lett 245: 204-208.